Skip to Content

NAT 30 mg (Oseltamivir Phosphate 30 mg (base))

Pill with imprint NAT 30 mg is Yellow, Capsule-shape and has been identified as Oseltamivir Phosphate 30 mg (base). It is supplied by Alvogen Inc..

Oseltamivir is used in the treatment of swine flu; avian influenza; influenza prophylaxis; influenza and belongs to the drug class neuraminidase inhibitors. Risk cannot be ruled out during pregnancy. Oseltamivir 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for NAT 30 mg

Oseltamivir phosphate 30 mg (base) NAT 30 mg
Oseltamivir phosphate 30 mg (base) NAT 30 mg
Oseltamivir phosphate 30 mg (base) NAT 30 mg

Oseltamivir Phosphate

Imprint
NAT 30 mg
Strength
30 mg (base)
Color
Yellow
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Neuraminidase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen Inc.
National Drug Code (NDC)
47781-0468
Inactive Ingredients
croscarmellose sodium, povidone k30, sodium stearyl fumarate, corn starch, magnesium silicate, ferric oxide red, ferric oxide yellow, titanium dioxide, alcohol, ammonia, butyl alcohol, FD&C Blue No. 2, isopropyl alcohol, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.